STAT+: Pharmalittle: Three big drugmakers spent less on lobbying after leaving PhRMA; EMA reviews CRO over data concerns
Three companies that left the Pharmaceutical Research & Manufacturers of America spent less on lobbying afterward.
by Ed Silverman
Jul 24, 2023
1 minute
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online calls, meetings, and deadlines has returned. But what
You’re reading a preview, subscribe to read more.
Start your free 30 days